Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance

This study has been completed.
Information provided by (Responsible Party):
Nantes University Hospital Identifier:
First received: January 12, 2007
Last updated: April 2, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)